Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Shlien

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Elife|March 6, 2014
A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cellsTony Ly, Yasmeen Ahmad, Adam Shlien, et al.
Cancer Research Communications|November 30, 2023
SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in NeuroblastomaIvette Valencia-Sama, Lynn Kee, Gabriella Christopher, et al.
Cancer Research|January 6, 2010
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcomaIvan Pasic, Adam Shlien, Adam D Durbin, et al.
NAR Cancer|January 20, 2022
Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcomaGarrett T Graham, Saravana P Selvanathan, Stefan K Zöllner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2008
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndromeAdam Shlien, Uri Tabori, Christian R Marshall, et al.
Pediatric Blood & Cancer|August 4, 2020
TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemiaKarin Langenberg-Ververgaert, Samuele Renzi, Fabio Fuligni, et al.
Journal of Pediatric Hematology/Oncology|May 20, 2020
Failure of Romidepsin to Treat Relapsed/Refractory Peripheral T-Cell Lymphoma in Children: A Single-center ExperienceSneha Tandon, Jack Bartram, Lianna Kyriakopoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|February 24, 2018
DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid CarcinomaJonathan D Wasserman, Nelly Sabbaghian, Somayyeh Fahiminiya, et al.
Genome Biology|October 10, 2014
OncoCis: annotation of cis-regulatory mutations in cancerDilmi Perera, Diego Chacon, Julie A I Thoms, et al.
Journal of Child Neurology|December 6, 2018
mTOR Inhibitors as a New Therapeutic Strategy in Treatment Resistant Epilepsy in Hemimegalencephaly: A Case ReportQi Xu, Shimrit Uliel-Sibony, Christopher Dunham, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Elife|March 6, 2014
A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cellsTony Ly, Yasmeen Ahmad, Adam Shlien, et al.
Cancer Research Communications|November 30, 2023
SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in NeuroblastomaIvette Valencia-Sama, Lynn Kee, Gabriella Christopher, et al.
Cancer Research|January 6, 2010
Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcomaIvan Pasic, Adam Shlien, Adam D Durbin, et al.
NAR Cancer|January 20, 2022
Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcomaGarrett T Graham, Saravana P Selvanathan, Stefan K Zöllner, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2008
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndromeAdam Shlien, Uri Tabori, Christian R Marshall, et al.
Pediatric Blood & Cancer|August 4, 2020
TERT promotor variant associated with poor clinical outcome in a patient with novel RBM15-MKL1 fusion-positive pediatric acute megakaryoblastic leukemiaKarin Langenberg-Ververgaert, Samuele Renzi, Fabio Fuligni, et al.
Journal of Pediatric Hematology/Oncology|May 20, 2020
Failure of Romidepsin to Treat Relapsed/Refractory Peripheral T-Cell Lymphoma in Children: A Single-center ExperienceSneha Tandon, Jack Bartram, Lianna Kyriakopoulou, et al.
The Journal of Clinical Endocrinology and Metabolism|February 24, 2018
DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid CarcinomaJonathan D Wasserman, Nelly Sabbaghian, Somayyeh Fahiminiya, et al.
Genome Biology|October 10, 2014
OncoCis: annotation of cis-regulatory mutations in cancerDilmi Perera, Diego Chacon, Julie A I Thoms, et al.
Journal of Child Neurology|December 6, 2018
mTOR Inhibitors as a New Therapeutic Strategy in Treatment Resistant Epilepsy in Hemimegalencephaly: A Case ReportQi Xu, Shimrit Uliel-Sibony, Christopher Dunham, et al.
Pageof 11